Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium

被引：88
|
作者：
Yee, Sook Wah [1 ,2 ]
Brackman, Deanna J. [1 ,2 ]
Ennis, Elizabeth A. [1 ,2 ]
Sugiyama, Yuichi [3 ]
Kamdem, Landry K. [4 ]
Blanchard, Rebecca [5 ]
Galetin, Aleksandra [6 ]
Zhang, Lei [7 ]
Giacomini, Kathleen M. [1 ,2 ,8 ]
机构：
[1] Univ Calif San Francisco, Sch Pharm, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Sch Med, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[3] RIKEN, Res Cluster Innovat, RIKEN Innovat Ctr, Sugiyama Lab, Yokohama, Kanagawa, Japan
[4] Harding Univ, Coll Pharm, Dept Pharmaceut Sci, Searcy, AR USA
[5] CRISPR Therapeut, Cambridge, MA USA
[6] Univ Manchester, Sch Hlth Sci, Ctr Appl Pharmacokinet Res, Manchester, Lancs, England
[7] US FDA, Off Res & Stand, Off Gener Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[8] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 104卷 / 05期
关键词：
D O I：
10.1002/cpt.1098
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Advances in genomic technologies have led to a wealth of information identifying genetic polymorphisms in membrane transporters, specifically how these polymorphisms affect drug disposition and response. This review describes the current perspective of the International Transporter Consortium(ITC) on clinically important polymorphisms in membrane transporters. ITC suggests that, in addition to previously recommended polymorphisms in ABCG2 (BCRP) and SLCO1B1 (OATP1B1), polymorphisms in the emerging transporter, SLC22A1 (OCT1), be considered during drug development. Collectively, polymorphisms in these transporters are important determinants of interindividual differences in the levels, toxicities, and response to many drugs.
引用
收藏
页码：803 / 817
页数：15
相关论文
共 50 条
  • [21] Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance
    Zamek-Gliszczynski, Maciej J.
    Sangha, Vishal
    Shen, Hong
    Feng, Bo
    Wittwer, Matthias B.
    Varma, Manthena V. S.
    Liang, Xiaomin
    Sugiyama, Yuichi
    Zhang, Lei
    Bendayan, Reina
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (03) : 485 - 500
  • [22] Circadian regulation of transporter expression and implications for drug disposition
    Pacha, Jiri
    Balounova, Katerina
    Sotak, Matus
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (04) : 425 - 439
  • [23] Influence of serotonin transporter gene polymorphisms on clozapine response in Brazilian schizophrenics
    Kohlrausch, Fabiana B.
    Salatino-Oliveira, Angelica
    Gama, Clarissa S.
    Lobato, Maria Ines
    Belmonte-de-Abreu, Paulo
    Hutz, Mara H.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2010, 44 (16) : 1158 - 1162
  • [24] The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA
    Huang, S-M
    Zhang, L.
    Giacomini, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (01) : 32 - 36
  • [25] Regulation of Drug Transport Proteins-From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium
    Brouwer, Kim L. R.
    Evers, Raymond
    Hayden, Elizabeth
    Hu, Shuiying
    Li, Cindy Yanfei
    zu Schwabedissen, Henriette E. Meyer
    Neuhoff, Sibylle
    Oswald, Stefan
    Piquette-Miller, Micheline
    Saran, Chitra
    Sjostedt, Noora
    Sprowl, Jason A.
    Stahl, Simone H.
    Yue, Wei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (03) : 461 - 484
  • [26] Molecular properties associated with transporter-mediated drug disposition
    Varma, Manthena V.
    Lai, Yurong
    El-Kattan, Ayman F.
    ADVANCED DRUG DELIVERY REVIEWS, 2017, 116 : 92 - 99
  • [27] HTR1A and serotonin transporter gene polymorphisms influence therapeutic response
    Laika, Barbara
    Leucht, Stefan
    Heres, Stephan
    Steimer, Werner
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 486 - 486
  • [28] Predicting drug absorption and disposition: transporter, solubility and elimination interplay
    Benet, L. Z.
    Wu, Chi-Yuan
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S108 - S109
  • [29] The Important Role of Transporter Structures in Drug Disposition, Efficacy, and Toxicity
    Fu, Tingting
    Zeng, Su
    Zheng, Qingchuan
    Zhu, Feng
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (10) : 1316 - 1323
  • [30] Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?
    McLean, Cheynne
    Wilson, Aze
    Kim, Richard B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 : S40 - S58
12345